Nirvana Group with CEO Arshad Lasi today on Blunt Business only on Cannabis Radio. Our next guest runs one of the most prominent and well-known cannabis companies in Oklahoma, which boasts a sprawling 30-acre cultivation facility, 3,000 square foot production center, wholesale distribution company, multiple house brands, and an ever-expanding roster of medical dispensaries. Delays in implementing Oklahoma’s “seed-to-sale” tracking system for medical marijuana have sowed confusion for businesses in the fast-growing cannabis industry as law enforcement authorities step up their enforcement efforts for illicit marijuana products. Oklahoma voters approved medical marijuana in 2018 under State Question 788. Most states with legal medical or recreational cannabis markets have some type of tracking system to verify that products are grown, processed, transported, and sold under the law.
Enjoy this episode?
Subscribe to Blunt Business for new episodes.
More from Blunt Business
A Psychedelic and Cannabis Research Revolution On the Horizon?
Blunt Business
This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research into psychedelics like LSD, psilocybin, and ibogaine for treating mental health disorders.